Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith A Rodvold

Showing results (61-70 of 104) with videos related to

Pageof 11
Sort By:
Antimicrobial Agents and Chemotherapy|May 8, 2013
Intrapulmonary pharmacokinetics of GSK2251052 in healthy volunteersDavid Tenero, Gary Bowers, Keith A Rodvold, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2002
Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faeciumManjunath P Pai, Keith A Rodvold, Paul C Schreckenberger, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 13, 2006
Pharmacists' perceptions of the effectiveness of antimicrobial control programsGail S Itokazu, David N Schwartz, Kevin W Garey, et al.
Diagnostic Microbiology and Infectious Disease|August 5, 2006
Population pharmacokinetic modeling and Monte Carlo simulation of varying doses of intravenous metronidazoleKelly A Sprandel, George L Drusano, David W Hecht, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2006
Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg doseKeith A Rodvold, Mark H Gotfried, Michael Cwik, et al.
Neurological Research|May 15, 2004
Fluctuations in vancomycin CNS tissue concentrations following intermittent and continuous infusions in the ratMark S Luer, Kathryn K Neill, Billy J Gurley, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2018
Pharmacokinetics of Telavancin at Fixed Doses in Normal-Body-Weight and Obese (Classes I, II, and III) Adult SubjectsKristen L Bunnell, Manjunath P Pai, Monica Sikka, et al.
Antimicrobial Agents and Chemotherapy|October 30, 2013
Are vancomycin trough concentrations adequate for optimal dosing?Michael N Neely, Gilmer Youn, Brenda Jones, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2015
Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult SubjectsEric Wenzler, Mark H Gotfried, Jeffrey S Loutit, et al.
Antimicrobial Agents and Chemotherapy|November 6, 2013
Penetration of GSK1322322 into epithelial lining fluid and alveolar macrophages as determined by bronchoalveolar lavageOdin J Naderer, Keith A Rodvold, Lori S Jones, et al.
Pageof 11

Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Antimicrobial Agents and Chemotherapy|May 8, 2013
Intrapulmonary pharmacokinetics of GSK2251052 in healthy volunteersDavid Tenero, Gary Bowers, Keith A Rodvold, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2002
Risk factors associated with the development of infection with linezolid- and vancomycin-resistant Enterococcus faeciumManjunath P Pai, Keith A Rodvold, Paul C Schreckenberger, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 13, 2006
Pharmacists' perceptions of the effectiveness of antimicrobial control programsGail S Itokazu, David N Schwartz, Kevin W Garey, et al.
Diagnostic Microbiology and Infectious Disease|August 5, 2006
Population pharmacokinetic modeling and Monte Carlo simulation of varying doses of intravenous metronidazoleKelly A Sprandel, George L Drusano, David W Hecht, et al.
The Journal of Antimicrobial Chemotherapy|October 3, 2006
Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg doseKeith A Rodvold, Mark H Gotfried, Michael Cwik, et al.
Neurological Research|May 15, 2004
Fluctuations in vancomycin CNS tissue concentrations following intermittent and continuous infusions in the ratMark S Luer, Kathryn K Neill, Billy J Gurley, et al.
Antimicrobial Agents and Chemotherapy|January 10, 2018
Pharmacokinetics of Telavancin at Fixed Doses in Normal-Body-Weight and Obese (Classes I, II, and III) Adult SubjectsKristen L Bunnell, Manjunath P Pai, Monica Sikka, et al.
Antimicrobial Agents and Chemotherapy|October 30, 2013
Are vancomycin trough concentrations adequate for optimal dosing?Michael N Neely, Gilmer Youn, Brenda Jones, et al.
Antimicrobial Agents and Chemotherapy|September 10, 2015
Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult SubjectsEric Wenzler, Mark H Gotfried, Jeffrey S Loutit, et al.
Antimicrobial Agents and Chemotherapy|November 6, 2013
Penetration of GSK1322322 into epithelial lining fluid and alveolar macrophages as determined by bronchoalveolar lavageOdin J Naderer, Keith A Rodvold, Lori S Jones, et al.
Pageof 11